Min L - Search Results

1

Association of ipilimumab therapy for advanced melanoma with secondary adrenal insufficiency: a case series.

Min L, Vaidya A, Becker C. Min L, et al. Endocr Pract. 2012 May-Jun;18(3):351-5. doi: 10.4158/EP11273.OR. Endocr Pract. 2012. PMID: 22138079 Free PMC article.

2

Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy.

Min L, Vaidya A, Becker C. Min L, et al. Eur J Endocrinol. 2011 Feb;164(2):303-7. doi: 10.1530/EJE-10-0833. Epub 2010 Nov 18. Eur J Endocrinol. 2011. PMID: 21088057 Free PMC article.

3

Improving the management of diabetes in hospitalized patients: the results of a computer-based house staff training program.

Vaidya A, Hurwitz S, Yialamas M, Min L, Garg R. Vaidya A, et al. Among authors: min l. Diabetes Technol Ther. 2012 Jul;14(7):610-8. doi: 10.1089/dia.2011.0258. Epub 2012 Apr 23. Diabetes Technol Ther. 2012. PMID: 22524682 Free PMC article.

4

Ipilimumab-induced autoimmune adrenalitis.

Min L, Ibrahim N. Min L, et al. Lancet Diabetes Endocrinol. 2013 Nov;1(3):e15. doi: 10.1016/S2213-8587(13)70031-7. Epub 2013 Jul 9. Lancet Diabetes Endocrinol. 2013. PMID: 24622375 Free PMC article. No abstract available.

5

Anti-PD1 following ipilimumab for mucosal melanoma: durable tumor response associated with severe hypothyroidism and rhabdomyolysis.

Min L, Hodi FS. Min L, et al. Cancer Immunol Res. 2014 Jan;2(1):15-8. doi: 10.1158/2326-6066.CIR-13-0146. Epub 2013 Oct 7. Cancer Immunol Res. 2014. PMID: 24778161 Free PMC article.

6

Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study.

Min L, Hodi FS, Giobbie-Hurder A, Ott PA, Luke JJ, Donahue H, Davis M, Carroll RS, Kaiser UB. Min L, et al. Clin Cancer Res. 2015 Feb 15;21(4):749-55. doi: 10.1158/1078-0432.CCR-14-2353. Epub 2014 Dec 23. Clin Cancer Res. 2015. PMID: 25538262 Free PMC article.

7

Corticosteroids and immune checkpoint blockade.

Min L, Hodi FS, Kaiser UB. Min L, et al. Aging (Albany NY). 2015 Aug;7(8):521-2. doi: 10.18632/aging.100797. Aging (Albany NY). 2015. PMID: 26298620 Free PMC article. No abstract available.

8

Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity.

Bresler SC, Min L, Rodig SJ, Walls AC, Xu S, Geng S, Hodi FS, Murphy GF, Lian CG. Bresler SC, et al. Among authors: min l. Lab Invest. 2017 Feb;97(2):207-216. doi: 10.1038/labinvest.2016.126. Epub 2016 Dec 5. Lab Invest. 2017. PMID: 27918555 Free article.

9

Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.

Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM. Barroso-Sousa R, et al. Among authors: min l. JAMA Oncol. 2018 Feb 1;4(2):173-182. doi: 10.1001/jamaoncol.2017.3064. JAMA Oncol. 2018. PMID: 28973656 Free PMC article.

10

Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Chang LS, Barroso-Sousa R, Tolaney SM, Hodi FS, Kaiser UB, Min L. Chang LS, et al. Among authors: min l. Endocr Rev. 2019 Feb 1;40(1):17-65. doi: 10.1210/er.2018-00006. Endocr Rev. 2019. PMID: 30184160 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,307 results

Search Page

Filters